Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Sustiva
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Sustiva and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using efavirenz together with dasabuvir is not recommended. These medications given in combination have been poorly tolerated and led to liver problems in some cases. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact. You should seek immediate medical attention if you develop fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, dark colored urine, light colored stools, and/or yellowing of the skin or eyes, as these may be signs and symptoms of liver damage. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:CONTRAINDICATED: Coadministration of efavirenz-based antiretroviral regimens with ombitasvir/paritaprevir/ritonavir plus dasabuvir has been reported to be poorly tolerated and resulted in liver enzyme elevations.
MANAGEMENT: Concomitant use of efavirenz with ombitasvir/paritaprevir/ritonavir plus dasabuvir is considered contraindicated.
- "Product Information. Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir)." AbbVie US LLC, North Chicago, IL.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Sustiva (Efavirenz Capsules)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Sustiva (Efavirenz Tablets)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Sustol
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Sustol injection
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-SuTan
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-SuTan-DM
- Sustiva-Omeclamox-Pak
- Sustiva-Omega-3 Fatty Acid Capsules
- Sustiva-Omega-3 Fatty Acids
- Sustiva-Omega-3 polyunsaturated fatty acids
- Sustiva-Omega-3-acid ethyl esters
- Sustiva-Omega-3-carboxylic acids